Read + Share
Amedeo Smart
Independent Medical Education
Bartlett NL, Hahn U, Kim WS, Fleury I, et al. Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma. J Clin Oncol 2025 Jan 7:JCO2402242. doi: 10.1200/JCO-24-02242.PMID: 39772655
Email
LinkedIn
Privacy Policy